Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression-Reference-Cited by-同舟云学术

Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression

Published:2013-05 Issue:7 Volume:49 Page:1715-1724
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Oguro Toshiki,Ishibashi Kei,Sugino Takashi,Hashimoto Koichi,Tomita Shintaro,Takahashi Norio,Yanagida Tomohiko,Haga Nobuhiro,Aikawa Ken,Suzutani Tatsuo,Yamaguchi Osamu,Kojima Yoshiyuki

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics, 1999;Landis;CA Cancer J Clin,1999

2. Renal cell carcinoma: incidental detection and pathological staging;Siow;J R Coll Surg Edinb,2000

3. Renal cell carcinoma: prognostic significance of incidentally detected tumors;Tsui;J Urol,2000

4. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

5. Sunitinib efficacy against advanced renal cell carcinoma;Motzer;J Urol,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets;Cancers;2024-02-23

2. Inflammatory Networks in Renal Cell Carcinoma;Cancers;2023-04-09

3. Cancer Stem Cells are Actually Stem Cells with Disordered Differentiation: the Monophyletic Origin of Cancer;Stem Cell Reviews and Reports;2023-01-17

4. Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential;Journal of Clinical Pharmacy and Therapeutics;2022-10-21

5. STAT3 and Its Pathways’ Dysregulation—Underestimated Role in Urological Tumors;Cells;2022-09-27